A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes
Abstract Smokers who switch completely to e-cigarettes may reduce their relative risk of tobacco-related disease. Effective nicotine delivery from e-cigarettes is important in consumer acceptance. We assessed whether protonated nicotine and e-cigarette devices delivering greater aerosol mass increas...
Guardado en:
Autores principales: | James K. Ebajemito, Michael McEwan, Nathan Gale, Oscar M. Camacho, George Hardie, Christopher J. Proctor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95642d38e7844b059c8b536763de053e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
From Tobacco Cigarettes to Electronic Cigarettes: The Two Sides of a Nicotine Coin
por: Ahmad Besaratinia
Publicado: (2021) -
Urinary Cotinine and Nicotine Dependence Levels in Regular Male Electronic Cigarette Users
por: Sri Wening Pamungkasningsih, et al.
Publicado: (2021) -
Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline
por: G. Batsikadze, et al.
Publicado: (2017) -
Nicotine delivery from the refill liquid to the aerosol via high-power e-cigarette device
por: Nathalie Prévôt, et al.
Publicado: (2017) -
Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention.
por: Amir Faour, et al.
Publicado: (2021)